Tata Chemicals

  • Market Cap: Small Cap
  • Industry: Commodity Chemicals
  • ISIN: INE092A01019
  • NSEID: TATACHEM
  • BSEID: 500770
INR
773.85
-8.3 (-1.06%)
BSENSE

Dec 05

BSE+NSE Vol: 2.89 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.89 lacs (-56.64%) Volume

Shareholding (Sep 2025)

FII

13.74%

Held by 174 FIIs

DII

0.06%

Held by 30 DIIs

Promoter

37.98%

When is the next results date for Tata Chemicals?

06-Jun-2025

No Upcoming Board Meetings

What does Tata Chemicals do?

06-Jun-2025

Tata Chemicals Ltd. is a large-cap company in the commodity chemicals industry, focusing on sustainable chemistry solutions. As of March 2025, it reported net sales of ₹3,509 Cr and a net profit of -₹56 Cr, with a market cap of ₹23,820 Cr.

Overview: <BR>Tata Chemicals Ltd. is a science-led sustainable chemistry solutions company operating in the commodity chemicals industry and is classified as a large-cap entity.<BR><BR>History: <BR>Tata Chemicals was incorporated as part of the Tata Group and has undergone various developments over the years. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 3,509 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -56 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 23,820 Cr (Large Cap)<BR><BR>Key Metrics: <BR>P/E: 71.00 <BR>Industry P/E: 63 <BR>Dividend Yield: 1.61% <BR>Debt-Equity: 0.26 <BR>Return on Equity: 1.54% <BR>Price to Book: 1.10<BR><BR>Contact Details: <BR>Address: Bombay House, 24 Homi Mody Street Fort Mumbai Maharashtra : 400001 <BR>Tel: 91-22-66658282 <BR>Email: investors@tatachemicals.com <BR>Website: http://www.tatachemicals.com

Read More

Who are in the management team of Tata Chemicals?

06-Jun-2025

As of March 2022, Tata Chemicals' management team includes R Mukundan (Managing Director & CEO), Rajiv Chandan (Company Secretary), and several independent directors, with N Chandrasekaran serving as the Non-Executive Chairman and Ratan N Tata as Chairman Emeritus. The team combines executive and independent members to guide the company's governance and strategy.

As of March 2022, the management team of Tata Chemicals includes the following individuals:<BR><BR>1. Rajiv Chandan - Company Secretary & Compliance Officer<BR>2. R Mukundan - Managing Director & CEO<BR>3. Vibha Paul Rishi - Independent Director<BR>4. S Padmanabhan - Director<BR>5. Ratan N Tata - Chairman Emeritus<BR>6. Padmini Khare Kaicker - Independent Director<BR>7. Zarir Langrana - Executive Director<BR>8. C V Natraj - Independent Director<BR>9. K B S Anand - Independent Director<BR>10. N Chandrasekaran - Chairman (Non-Executive)<BR>11. Rajiv Dube - Independent Director<BR><BR>This team comprises a mix of executive and independent directors, contributing to the governance and strategic direction of the company.

Read More

Has Tata Chemicals declared dividend?

06-Jun-2025

Yes, Tata Chemicals has declared a dividend of 110% (₹15 per share) with an ex-date of June 12, 2024. While the dividend yield is 1.61%, total returns over shorter periods have been negative, despite positive long-term performance.

Tata Chemicals Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 110%<BR>- Amount per share: 15<BR>- Ex-date: 12 Jun 2024<BR><BR>Dividend Yield: 1.61%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -16.85%, the dividend return was 0.99%, resulting in a total return of -15.86%.<BR><BR>Over the past year, the price return was -12.38%, the dividend return was 2.34%, leading to a total return of -10.04%.<BR><BR>In the 2-year period, the price return was -6.15%, the dividend return was 2.66%, resulting in a total return of -3.49%.<BR><BR>For the 3-year period, the price return was -1.71%, the dividend return was 5.48%, culminating in a total return of 3.77%.<BR><BR>In the last 4 years, the price return was 24.75%, the dividend return was 7.76%, resulting in a total return of 32.51%.<BR><BR>Over the past 5 years, the price return was 192.35%, the dividend return was 21.34%, leading to a total return of 213.69%.<BR><BR>Overall, Tata Chemicals has declared a significant dividend, but the total returns over shorter periods have been negative, indicating a challenging performance in the near term despite positive long-term returns.

Read More

Who are the peers of the Tata Chemicals?

03-Jun-2025

Tata Chemicals' peers include Chemplast Sanmar, GHCL, India Glycols, and others. In terms of management risk, growth, and capital structure, Tata Chemicals shows average performance compared to its peers, with a 1-year return of -14.63%.

Peers: The peers of Tata Chemicals are Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Gujarat Alkalies, Grauer & Weil, Tanfac Inds., Thirumalai Chem., Blue Pearl Agri, and J.G.Chemicals.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL, Chemplast Sanmar, and Tanfac Inds., while Average management risk is found at Tata Chemicals, India Glycols, Thirumalai Chem., Grauer & Weil, and J.G.Chemicals. Below Average management risk is present at Fischer Medical, Gujarat Alkalies, and Blue Pearl Agri. Growth is Excellent at Tanfac Inds., while Below Average growth is seen at Chemplast Sanmar, GHCL, Tata Chemicals, India Glycols, Gujarat Alkalies, Grauer & Weil, and Thirumalai Chem. Average growth is noted at Fischer Medical, and the rest. Capital Structure is Excellent at GHCL, Gujarat Alkalies, and Tanfac Inds., while Average capital structure is found at Tata Chemicals and Thirumalai Chem., and Below Average at Chemplast Sanmar, India Glycols, and Fischer Medical.<BR><BR>Return Snapshot: The peer with the highest 1-year return is India Glycols at 150.27%, while the lowest is Blue Pearl Agri with a return that is not available. Tata Chemicals has a 1-year return of -14.63%, which is lower than both of these peers. Additionally, peers with negative six-month returns include Gujarat Alkalies, Grauer & Weil, and Blue Pearl Agri.

Read More

Who are the top shareholders of the Tata Chemicals?

17-Jul-2025

The top shareholders of Tata Chemicals include Tata Sons Private Limited with 31.9%, mutual funds with 9.15%, foreign institutional investors at 13.3%, and individual investors holding 22.92%. There are no pledged promoter holdings, and the Life Insurance Corporation of India - P & Gs Fund is the largest public shareholder with a minimal stake.

The top shareholders of Tata Chemicals include the promoters, with Tata Sons Private Limited holding the largest share at 31.9%. Additionally, mutual funds collectively hold 9.15% through 40 different schemes, while foreign institutional investors (FIIs) own 13.3% across 155 entities. Individual investors account for 22.92% of the holdings. Notably, there are no pledged promoter holdings, and the highest public shareholder is the Life Insurance Corporation of India - P & Gs Fund, which holds a minimal stake.

Read More

How big is Tata Chemicals?

24-Jul-2025

As of 24th July, Tata Chemicals Ltd. has a market capitalization of 24,733.00 Cr, with recent net sales of 14,887.00 Cr and a net profit of 235.00 Cr. The company has shareholder's funds of 21,594.00 Cr and total assets of 37,750.00 Cr.

As of 24th July, Tata Chemicals Ltd. has a market capitalization of 24,733.00 Cr and is classified as a Large Cap company.<BR><BR>In the latest four quarters, Tata Chemicals reported Net Sales of 14,887.00 Cr and a Net Profit of 235.00 Cr.<BR><BR>For the latest annual period ending March 2025, the company has Shareholder's Funds amounting to 21,594.00 Cr and Total Assets of 37,750.00 Cr.

Read More

How has been the historical performance of Tata Chemicals?

01-Nov-2025

Tata Chemicals has shown a declining trend in net sales and profitability, with net sales dropping from 16,789 Cr in Mar'23 to 14,887 Cr in Mar'25, and profit after tax decreasing from 381 Cr to 200 Cr in the same period. The company's operating profit margin also fell significantly, indicating reduced operational efficiency.

Answer:<BR>The historical performance of Tata Chemicals shows a fluctuating trend in net sales and profitability over the years, with a notable decline in recent periods.<BR><BR>Breakdown:<BR>Tata Chemicals reported net sales of 14,887.00 Cr in Mar'25, down from 15,421.00 Cr in Mar'24 and 16,789.00 Cr in Mar'23, indicating a downward trend from a peak in Mar'23. The total operating income followed a similar pattern, with a decrease to 14,887.00 Cr in Mar'25 from 15,421.00 Cr in Mar'24. Operating profit (PBDIT) also decreased significantly to 2,178.00 Cr in Mar'25 from 3,133.00 Cr in Mar'24 and 4,040.00 Cr in Mar'23, reflecting a decline in operational efficiency, as evidenced by the operating profit margin dropping to 13.12% in Mar'25 from 18.46% in Mar'24. Profit before tax fell sharply to 367.00 Cr in Mar'25 from 762.00 Cr in Mar'24, and profit after tax decreased to 200.00 Cr from 381.00 Cr in the same period. The consolidated net profit also declined to 235.00 Cr in Mar'25 from 268.00 Cr in Mar'24, contrasting sharply with the high of 2,317.00 Cr in Mar'23. On the balance sheet, total assets increased to 37,750.00 Cr in Mar'25 from 36,711.00 Cr in Mar'24, while total liabilities also rose to 37,750.00 Cr from 36,711.00 Cr, indicating a consistent leverage level. Cash flow from operating activities decreased to 1,761.00 Cr in Mar'25 from 3,016.00 Cr in Mar'24, contributing to a net cash inflow of 123.00 Cr, a recovery from a net outflow of -83.00 Cr in Mar'24. Overall, Tata Chemicals has experienced significant fluctuations in its financial performance, particularly in profitability and cash flow, over the past few years.

Read More

Are Tata Chemicals latest results good or bad?

02-Nov-2025

Tata Chemicals' latest Q2 FY26 results are concerning, with a 69.44% drop in net profit and a significant contraction in operating margins, indicating substantial operational challenges and a negative outlook.

Tata Chemicals' latest results for Q2 FY26 indicate a challenging financial situation. The consolidated net profit plummeted to ₹77 crores, reflecting a significant decline of 69.44% quarter-on-quarter and 60.31% year-on-year. While net sales showed a modest increase of 4.25% from the previous quarter, they still fell 3.05% compared to the same period last year.<BR><BR>Operating margins also contracted sharply, dropping to 13.85% from 17.45% in the previous quarter, and the PAT margin fell to 3.97% from 8.50%. This deterioration in profitability is concerning, especially given the company's reliance on other income, which constituted a significant portion of its profit before tax.<BR><BR>Overall, the results suggest that Tata Chemicals is facing substantial operational challenges, with weak returns on equity and capital employed, alongside rising costs and competitive pressures in the commodity chemicals sector. The outlook appears negative, indicating that the latest results are more bad than good.

Read More

Should I buy, sell or hold Tata Chemicals?

02-Nov-2025

Is Tata Chemicals overvalued or undervalued?

07-Nov-2025

As of November 6, 2025, Tata Chemicals is considered overvalued due to its high PE ratio of 60.22 and poor stock performance, significantly underperforming the Sensex with a return of -24.10%.

As of 6 November 2025, Tata Chemicals' valuation grade has moved from fair to expensive, indicating a shift towards overvaluation. The company is currently assessed as overvalued based on its high PE ratio of 60.22, an EV to EBIT of 38.86, and a notably low Price to Book Value of 0.10. These ratios suggest that the market is pricing the stock at a premium compared to its underlying fundamentals.<BR><BR>In comparison to its peers, Tata Chemicals stands out with a significantly higher PE ratio than Adani Enterprises, which has a PE of 127.79, and is also more expensive than DCM Shriram, which is valued attractively with a PE of 26.89. Furthermore, Tata Chemicals has underperformed the Sensex significantly over the past year, with a stock return of -24.10% compared to the Sensex's 3.65% return. Overall, the data supports the conclusion that Tata Chemicals is overvalued in the current market environment.

Read More

Is Tata Chemicals technically bullish or bearish?

29-Nov-2025

As of November 28, 2025, Tata Chemicals exhibits a strong bearish trend, supported by multiple indicators including bearish MACD, Bollinger Bands, and moving averages across weekly and monthly time frames.

As of 28 November 2025, the technical trend for Tata Chemicals has changed from mildly bearish to bearish. The current stance is bearish with a strong indication from multiple indicators. The MACD is bearish on both the weekly and monthly time frames, and Bollinger Bands also reflect a bearish outlook in both time frames. Daily moving averages confirm a bearish trend, while the KST is bearish on both weekly and monthly levels. Dow Theory indicates a mildly bearish stance on the weekly and monthly charts, and the OBV is also mildly bearish. Overall, the combination of these indicators suggests a strong bearish sentiment for Tata Chemicals.

Read More

Why is Tata Chemicals falling/rising?

04-Dec-2025

As of 04-Dec, Tata Chemicals Ltd. is facing a decline in stock price, currently at 782.15, down -1.1 (-0.14%), and has fallen for six consecutive days, totaling a -4.11% drop. The stock has significantly underperformed the Sensex over various periods, with a year-to-date decline of -25.47% and concerns about its financial health due to high debt and poor long-term growth prospects.

As of 04-Dec, Tata Chemicals Ltd. is experiencing a decline in its stock price, currently at 782.15, which reflects a change of -1.1 (-0.14%). The stock has been on a downward trend, having fallen for the last six consecutive days, resulting in a total decline of -4.11% during this period. This consistent drop is compounded by the stock's performance over the past week, where it has underperformed the benchmark Sensex, showing a decrease of -3.32% compared to the Sensex's -0.53%.<BR><BR>Further analysis reveals that Tata Chemicals has significantly underperformed over longer periods as well. Year-to-date, the stock has dropped -25.47%, while the Sensex has gained +9.12%. Over the past year, the stock's return is -30.49%, starkly contrasting with the Sensex's +5.32% return. Additionally, the stock is trading lower than its moving averages across various time frames, indicating a bearish trend.<BR><BR>The company is also close to its 52-week low, being only 3.29% away from Rs 756.45. Despite a rise in investor participation, with delivery volume increasing by 180.27% against the 5-day average, the overall sentiment remains negative due to poor long-term growth prospects. The operating profit has declined at an annual rate of -2.09% over the last five years, and profits have fallen by -41.2% over the past year.<BR><BR>Moreover, the stock's high debt-equity ratio of 0.92 times and the lowest debtors turnover ratio of 0.71 times further contribute to concerns about its financial health. Given these factors, the stock's consistent underperformance against benchmarks and the negative financial indicators suggest that Tata Chemicals is currently in a downward trajectory.

Read More
iScoreScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate -2.09% of over the last 5 years

 
2

Flat results in Sep 25

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 19,723 Cr (Small Cap)

stock-summary
P/E

53.00

stock-summary
Industry P/E

78

stock-summary
Dividend Yield

1.41%

stock-summary
Debt Equity

0.28

stock-summary
Return on Equity

1.65%

stock-summary
Price to Book

0.89

Revenue and Profits:
Net Sales:
3,877 Cr
(Quarterly Results - Sep 2025)
Net Profit:
77 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.41%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.15%
0%
-17.15%
6 Months
-16.99%
1.15%
-15.84%
1 Year
-31.99%
0.98%
-31.01%
2 Years
-21.3%
2.52%
-18.78%
3 Years
-26.81%
4.50%
-22.31%
4 Years
-14.96%
6.36%
-8.6%
5 Years
57.59%
13.83%
71.42%

Latest dividend: 11 per share ex-dividend date: Jun-12-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

Why is Tata Chemicals falling/rising?

Recent Price Movements and Market Comparison

Tata Chemicals has experienced a notable decline over recent periods, with the stock falling by 3.97% in the past week compared to a modest 0.59% drop in the Sensex. Over the last month, the stock has shed 10.51%, while the Sensex gained 1.34%. Year-to-date, the stock is down 25.37%, starkly contrasting with the Sensex’s 8.92% rise. The one-year return for Tata Chemicals stands at a negative 31.03%, whereas the benchmark index has appreciated by 5.27%. Even over three and five years, the stock has lagged significantly behind the Sensex, underperforming by nearly 60 percentage points in the three-year period and by almost 20 percentage points over five years.

The stock is currently trading close to its 52-week low, just 3.42%...

Read More
Announcements stock-summary

Disclosure Under Regulation 30 (5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)

01-Dec-2025 | Source : BSE

Disclosure under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)

Announcement under Regulation 30 (LODR)-Credit Rating

01-Dec-2025 | Source : BSE

Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Intimation Under Regulations 30 And 51 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)

21-Nov-2025 | Source : BSE

Intimation under Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Tata Chemicals Ltd. has declared 110% dividend, ex-date: 12 Jun 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.09%
EBIT Growth (5y)
-2.09%
EBIT to Interest (avg)
3.97
Debt to EBITDA (avg)
2.92
Net Debt to Equity (avg)
0.28
Sales to Capital Employed (avg)
0.54
Tax Ratio
23.60%
Dividend Payout Ratio
142.72%
Pledged Shares
0
Institutional Holding
35.94%
ROCE (avg)
6.55%
ROE (avg)
5.64%
Valuation key factors
Factor
Value
P/E Ratio
53
Industry P/E
78
Price to Book Value
0.88
EV to EBIT
32.23
EV to EBITDA
13.39
EV to Capital Employed
0.91
EV to Sales
1.77
PEG Ratio
NA
Dividend Yield
1.42%
ROCE (Latest)
2.82%
ROE (Latest)
1.65%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 37 Schemes (9.9%)

FIIs

Held by 174 FIIs (13.74%)

Promoter with highest holding

Tata Sons Private Limited (31.9%)

Highest Public shareholder

Life Insurance Corporation Of India - P & Gs Fund (9.24%)

Individual Investors Holdings

22.24%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 4.25% vs 5.98% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -69.44% vs 550.00% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,877.00",
          "val2": "3,719.00",
          "chgp": "4.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "537.00",
          "val2": "649.00",
          "chgp": "-17.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "144.00",
          "val2": "147.00",
          "chgp": "-2.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-65.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "77.00",
          "val2": "252.00",
          "chgp": "-69.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.85%",
          "val2": "17.45%",
          "chgp": "-3.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -2.47% vs -5.21% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -4.36% vs -64.17% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,596.00",
          "val2": "7,788.00",
          "chgp": "-2.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,186.00",
          "val2": "1,192.00",
          "chgp": "-0.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "291.00",
          "val2": "278.00",
          "chgp": "4.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-65.00",
          "val2": "15.00",
          "chgp": "-533.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "329.00",
          "val2": "344.00",
          "chgp": "-4.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.61%",
          "val2": "15.31%",
          "chgp": "0.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -4.75% vs -3.52% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -73.97% vs -30.47% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11,378.00",
          "val2": "11,946.00",
          "chgp": "-4.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,626.00",
          "val2": "2,404.00",
          "chgp": "-32.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "426.00",
          "val2": "400.00",
          "chgp": "6.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-55.00",
          "val2": "111.00",
          "chgp": "-149.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "291.00",
          "val2": "1,118.00",
          "chgp": "-73.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.29%",
          "val2": "20.12%",
          "chgp": "-5.83%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -3.46% vs -8.15% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -12.31% vs -88.43% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14,887.00",
          "val2": "15,421.00",
          "chgp": "-3.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,953.00",
          "val2": "2,847.00",
          "chgp": "-31.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "563.00",
          "val2": "530.00",
          "chgp": "6.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-92.00",
          "val2": "-875.00",
          "chgp": "89.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "235.00",
          "val2": "268.00",
          "chgp": "-12.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.12%",
          "val2": "18.46%",
          "chgp": "-5.34%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQstock-summary
Sep'25
Jun'25
Change(%)
Net Sales
3,877.00
3,719.00
4.25%
Operating Profit (PBDIT) excl Other Income
537.00
649.00
-17.26%
Interest
144.00
147.00
-2.04%
Exceptional Items
-65.00
0.00
Consolidate Net Profit
77.00
252.00
-69.44%
Operating Profit Margin (Excl OI)
13.85%
17.45%
-3.60%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 4.25% vs 5.98% in Jun 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -69.44% vs 550.00% in Jun 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
7,596.00
7,788.00
-2.47%
Operating Profit (PBDIT) excl Other Income
1,186.00
1,192.00
-0.50%
Interest
291.00
278.00
4.68%
Exceptional Items
-65.00
15.00
-533.33%
Consolidate Net Profit
329.00
344.00
-4.36%
Operating Profit Margin (Excl OI)
15.61%
15.31%
0.30%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -2.47% vs -5.21% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is -4.36% vs -64.17% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
11,378.00
11,946.00
-4.75%
Operating Profit (PBDIT) excl Other Income
1,626.00
2,404.00
-32.36%
Interest
426.00
400.00
6.50%
Exceptional Items
-55.00
111.00
-149.55%
Consolidate Net Profit
291.00
1,118.00
-73.97%
Operating Profit Margin (Excl OI)
14.29%
20.12%
-5.83%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -4.75% vs -3.52% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -73.97% vs -30.47% in Dec 2023

Annual Results Snapshot (Consolidated) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
14,887.00
15,421.00
-3.46%
Operating Profit (PBDIT) excl Other Income
1,953.00
2,847.00
-31.40%
Interest
563.00
530.00
6.23%
Exceptional Items
-92.00
-875.00
89.49%
Consolidate Net Profit
235.00
268.00
-12.31%
Operating Profit Margin (Excl OI)
13.12%
18.46%
-5.34%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -3.46% vs -8.15% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -12.31% vs -88.43% in Mar 2024

stock-summaryCompany CV
About Tata Chemicals Ltd. stock-summary
stock-summary
Tata Chemicals Ltd.
Small Cap
Commodity Chemicals
Tata Chemicals Limited (TCL) is a science-led sustainable chemistry solutions Company and is a part of the Tata Group. The Company operates through two verticals, Basic Chemistry (Alkali Chemicals-soda ash, sodium bicarb, salt, silica & other halogen chemicals) and Specialty Products (specialty silica, prebiotics & formulations, agrochemicals and seeds).
Company Coordinates stock-summary
Company Details
Bombay House, 24 Homi Mody Street Fort Mumbai Maharashtra : 400001
stock-summary
Tel: 91-22-66658282
stock-summary
investors@tatachemicals.com
Registrar Details
TSR Darashaw Ltd, 6-10 , Haji Moosa Patrawala Indl. Est , 20 Dr.E.Moses Road , Mahalaxmi , Mumbai